News & Events category:
NIHR Manchester Biomedical Research Centre

Manchester University NHS Foundation Trust's (MFT) innovative approach to enhanced patient care.

A major clinical trial has shown that people with inflammatory conditions are able to improve the antibody response from a COVID-19 booster vaccination.

A revolutionary ward-based genetic test which can prevent stroke related death has received a UKCA product mark, paving the way for its introduction to the NHS.

A major UK study has discovered that the disturbed sleep patterns in patients hospitalised with COVID-19 was likely to be a driver of breathlessness.

The NIHR has awarded more than £96 million to 93 NHS organisations as part of a capital investment – with £2.26 million awarded to MFT.

A new platform has been announced, bringing together UK strengths in rare diseases research to improve diagnosis and treatment.

Manchester researchers have developed a way to improve the accuracy of breast cancer genetic testing for women from Ashkenazi Jewish backgrounds.

University of Manchester Chancellor Nazir Afzal OBE has become the 1,000th person in Greater Manchester to take part in a huge research project.